Bleomycin-induced pulmonary toxicity and treatment with infliximab: A case report

Victor Ge, Iouri Banakh, Ravindranath Tiruvoipati, Kavi Haji

Research output: Contribution to journalArticleOtherpeer-review

7 Citations (Scopus)

Abstract

Given the current understanding of bleomycin-induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF-α) inhibitors such as infliximab for late-stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.

Original languageEnglish
Pages (from-to)2011-2014
Number of pages4
JournalClinical Case Reports
Volume6
Issue number10
DOIs
Publication statusPublished - Oct 2018

Keywords

  • bleomycin
  • infliximab
  • intensive care
  • pulmonary toxicity
  • respiratory failure
  • treatment outcome

Cite this